iX Biopharma secures TGA GMP licence for its testing laboratory
SINGAPORE: iX Biopharma Ltd announced that its wholly-owned subsidiary, iX Syrinx has obtained the Good Manufacturing Practice (GMP) licence issued by the Therapeutic Goods Administration...
iX Biopharma inks agreement to supply medicinal cannabis wafer to the Australian market
SINGAPORE: Specialty pharmaceutical company iX Biopharma Ltd announced that its wholly-owned subsidiary, iX Syrinx has formalised a supply agreement with Cannatrek Medical Pty Ltd, a...